Drug prices could suffer on Greek exit from euro; Teva chair spends $37M-plus on company stock;

 @FiercePharma: Some non-ASCO news: If Greece leaves euro, drug pricing across E.U. would get even worse, EFPIA says--BloombergArticle | Follow @FiercePharma

> Teva ($TEVA) Chairman Phillip Frost bought 1 million shares on the company's first day of New York Stock Exchange trading, at prices ranging from $37.82 to $39.57. Report

> Allergan ($AGN) got the chance for a new trial in a case where a Botox patient claimed the injections left him disabled and won a $212 million jury verdict. More

> Regeneron Pharmaceuticals ($REGN) shares fell after an analyst said growth in sales of its new macular degeneration drug Eylea seems to be slowing down. News

> Human Genome Sciences' ($HGS) board once again rejected GlaxoSmithKline's ($GSK) $13-per-share buyout offer. Item

> Abbott Laboratories ($ABT) plans to add local manufacturing, sales and distribution capacity to its nutrition business in India. Story

> Provincial officials in Canada are demanding compensation from the federal government for any increases in drug prices that result from a free-trade deal with Europe. Article

> Japan's Astellas Pharma has officially opened its new, $150 million U.S. headquarters in the Chicago area. Report

Biotech News

 @FierceBiotech: Look out, Roche: GlaxoSmithKline aces pivotal studies for pair of melanoma drugs. Story | Follow @FierceBiotech

 @JohnCFierce: Updated my ASCO roundup story with regorafenib and Aveo study. More | Follow @JohnCFierce

 @RyanMFierce: My report on 5 next-gen software tools for biopharma R&D. Report | Follow @RyanMFierce

> Boehringer sights AZ and Roche drugs in targeted lung cancer fight. Article

> Ariad's ponatinib scores well in key leukemia study. More

> Merck beefs up bankroll for biotech startups. News

> Sources: AstraZeneca, Bristol make bids for Amylin. Story

Medical Devices News

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> SentreHEART pulls in $26M for surgical suture device. Article

> Device investment firm gets support from Medtronic, Abbott. News

> LabCorp grabs Medtox for $241M. More

> Boston Sci gets FDA nod for new stent sizes. Story

Biotech IT News

> Proteins computer-designed to block flu invasions. Story

> Accelrys software to support efforts in Texas to study rare cancers. Article

> NIH group to award up to $20B in IT contracts. More

> Dotmatics starts up mobile strategy with iPad app. News

And Finally... The telltale scent of old people confirmed in study. Report